checkAd
    Startseite > Aktien > Ardelyx > Nachrichten
    Ardelyx Aktie
    6,4600
     
    USD
    +0,16 %
    +0,0100 USD
    Letzter Kurs 02:00:00 Nasdaq
    6,4600
     
    USD
    10.800 STK
    Geldkurs 10.06.24
    6,4700
     
    USD
    125.000 STK
    Briefkurs 10.06.24
    ISIN: US0396971071 · WKN: A116X0 · SYM: ARDX · USA

    Neueste Nachrichten

    Ardelyx, Inc. Reports Employment Inducement Grants
    30.05.24 · globenewswire · Ardelyx
    Ardelyx to Participate at the 2024 Jefferies Global Healthcare Conference
    22.05.24 · globenewswire · Ardelyx
    Ardelyx Presents Additional Data at the 2024 Digestive Disease Week Conference on IBSRELA (tenapanor), a First-In-Class Treatment for IBS-C in Adults
    21.05.24 · globenewswire · Ardelyx
    Ardelyx Presents Additional Data at the NKF 2024 Spring Clinical Meetings on XPHOZAH (tenapanor)
    16.05.24 · globenewswire · Ardelyx
    Ardelyx, Inc. Reports Employment Inducement Grants
    14.05.24 · globenewswire · Ardelyx
    Ardelyx to Present Additional Data Supporting First-In-Class IBSRELA (tenapanor) for Adults with Irritable Bowel Syndrome with Constipation at the 2024 Digestive Disease Week Conference
    07.05.24 · globenewswire · Ardelyx
    Ardelyx Reports First Quarter 2024 Financial Results and Provides Business Update
    02.05.24 · globenewswire · Ardelyx
    Ardelyx to Present Additional Data Supporting First-In-Class XPHOZAH (tenapanor) for Adults with Chronic Kidney Disease on Dialysis at the National Kidney Foundation 2024 Spring Clinical Meetings
    01.05.24 · globenewswire · Ardelyx
    Ardelyx to Report First Quarter 2024 Financial Results on May 2, 2024
    18.04.24 · globenewswire · Ardelyx
    Ardelyx, Inc. Reports Employment Inducement Grants
    28.03.24 · globenewswire · Ardelyx
    Ardelyx Appoints Veteran BioPharma Executive, Mike Kelliher, as Executive Vice President, Corporate Development and Strategy
    25.03.24 · globenewswire · Ardelyx
    Ardelyx, Inc. Reports Employment Inducement Grants
    12.03.24 · globenewswire · Ardelyx